Apatite content of collagen materials dose-dependently increases pre-osteoblastic cell deposition of a cement line-like matrix.
Perrier
A
A
Université de Lyon, F42023, Saint-Etienne, France.
Dumas
V
V
Linossier
M T
MT
Fournier
C
C
Jurdic
P
P
Rattner
A
A
Vico
L
L
Guignandon
A
A
D016475:3T3 Cells; D000818:Animals; D001031:Apatites / Q000494:pharmacology*; D001672:Biocompatible Materials / Q000494:pharmacology*; D001696:Biomechanical Phenomena / Q000187:drug effects; D001843:Bone Cements / Q000494:pharmacology*; D001857:Bone Matrix / Q000187:drug effects / Q000378:metabolism*; D002113:Calcification, Physiologic / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D003094:Collagen / Q000494:pharmacology*; D005353:Fibronectins / Q000378:metabolism; D051379:Mice; D009842:Oligopeptides / Q000494:pharmacology; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D010641:Phenotype; D012995:Solubility / Q000187:drug effects; D013379:Substrate Specificity / Q000187:drug effects
D001031:Apatites; D001672:Biocompatible Materials; D001843:Bone Cements; D005353:Fibronectins; D009842:Oligopeptides; C047981:arginyl-glycyl-aspartic acid; D003094:Collagen